JSKN003 was granted Breakthrough Therapy Designation in China

DATROWAY launched in Japan as the first TROP2 directed therapy for patients with previously treated...

AstraZeneca offers early look at Datroway-Tagrisso combo in EGFR lung cancer as phase 3 trial...

Elevation Oncology to discontinue development of EO-3021, advancing EO-1022 while evaluating strategic options

Taiho Pharmaceutical to acquire next-generation ADC drug discovery company Araris Biotech

Oxford BioTherapeutics enters into a strategic collaboration with Roche to discover novel targets for antibody-based...